To be considered acceptable, in addition to control group to establish endpoint baseline, a minimum of 3 dose levels were required.
While empathy for victims of extreme violence is commendable, it's also the baseline minimum we expect of a kind, moral person (which I am sure Rowling is).
Study design consisted of a screening visit or phone call, baseline visit, minimum of one treatment and a follow-up phone call at 2 and 24 hours after each treatment.
The inclusion criteria for the randomized phase included histologic evidence of EoE (≥15 eos/hpf) from at least two levels of the esophagus within 10 weeks of the baseline period; a minimum of 4 days with dysphagia within 2 weeks of randomization; acceptable diary compliance (≥70% of days within 2 weeks of randomization); and ≥70% compliance with placebo at randomization.
Body core temperature dropped from 36.0 ± 0.7°C at baseline to a minimum of 35.7 ± 0.7°C, and increased significantly (p < 0.001) thereafter to 37.1 ± 0.7°C until the end of surgery.
For this study, the endpoint for clinical intervention was when any reduction in systolic BP was observed between baseline and a minimum of two consecutive visits under any dosage regimen.
Information on HbA1c (A1C), medication use and co-morbid conditions was extracted from the medical record up to 6 months prior to the addition of SU or TZD to MF (baseline), and a minimum of one year after the initiation of either SU or TZD.
We did not observe any significant changes in heart rate or blood pressure indicating beginning hypovolaemia.Body core temperature dropped slightly from 36.0 ± 0.7°C at baseline to a minimum of 35.7 ± 0.7°C (range 34.0.. 37.1°C), and increased significantly (p < 0.001) thereafter to 37.1 ± 0.7°C at the end of surgery (see Figure 1).
AD subjects had to present a baseline itch intensity of minimum 3 out of 10 on a Visual Analog Scale (VAS) in order to qualify, and an eczema-free area on the volar aspect of either forearm.
The success criteria for the primary outcome measurements were an improvement of a minimum of 12% above baseline in FEV1, an increase of at least 1.5 points over baseline in the VAS dyspnoea score immediately after the second nVNS and the absence of any serious device-related adverse events.
For example, Chan et al. set a baseline target (assumed minimum requirement) of 12 days of outdoor recreation per person per year and determined the space required to provide that level of service from data on park visitation.
